Literature DB >> 22270844

Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry.

W Zou1, C Yang, M Liu, W Su.   

Abstract

Naringin (CAS 10236-47-2), a flavanone glucoside widely present in fruits of citrus plants, has received extensive studies on its potential effects on health benefits and was recently demonstrated to be a putative antitussive. In this study, we determined the tissue distributions of naringin and its metabolites (naringenin and naringenin's conjugates) in rats to examine whether they undergo selective uptake by specific organs. Naringin was administered orally to rats at the dose of 42 mg/kg and the concentrations of naringin and its metabolites in tissue compartments were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The areas under curve values in the individual tissues decreased as follows: stomach, small intestine, liver, trachea, muscle, kidney, lung, fat, heart, spleen, ovary, testis, brain for naringin; and liver, stomach, small intestine, kidney, trachea, lung, testis, heart, ovary, fat, spleen, muscle, brain for total naringenin (including free and its conjugates). Naringin and total naringenin were rapidly and widely distributed to all the tissues except brain in rats. They had difficulties in crossing the blood-brain barrier. There are no accumulations in rats. This study identifying naringin in several organs including lung and trachea may explain its effects as antitussive. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270844     DOI: 10.1055/s-0031-1299746

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  10 in total

1.  Identification of Naringin Metabolites in Human Urine and Feces.

Authors:  Xuan Zeng; Yang Bai; Wei Peng; Weiwei Su
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

2.  Aerosolization Performance, Antitussive Effect and Local Toxicity of Naringenin-Hydroxypropyl-β-Cyclodextrin Inhalation Solution for Pulmonary Delivery.

Authors:  Minyi Guan; Xuan Zeng; Rui Shi; Yuying Zheng; Weiyang Fan; Weiwei Su
Journal:  AAPS PharmSciTech       Date:  2021-01-03       Impact factor: 3.246

3.  Assessment of the feed additive consisting of naringin for all animal species for the renewal of its authorisation (HealthTech Bio Actives, S.L.U. (HTBA)).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Birgit Dusemund; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul George Brantom; Johannes Westendorf; Jaume Galobart; Paola Manini; Fabiola Pizzo
Journal:  EFSA J       Date:  2022-04-22

4.  Human intestinal microbial metabolism of naringin.

Authors:  Wei Zou; Yulong Luo; Menghua Liu; Si Chen; Sheng Wang; Yichu Nie; Guohua Cheng; Weiwei Su; Kejian Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-17       Impact factor: 2.441

5.  Auraptene in the Peels of Citrus kawachiensis (Kawachi Bankan) Ameliorates Lipopolysaccharide-Induced Inflammation in the Mouse Brain.

Authors:  Satoshi Okuyama; Kana Yamamoto; Hirotomo Mori; Nobuki Toyoda; Morio Yoshimura; Yoshiaki Amakura; Takashi Yoshida; Kuniaki Sugawara; Masahiko Sudo; Mitsunari Nakajima; Yoshiko Furukawa
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-15       Impact factor: 2.629

6.  Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats.

Authors:  Shiuan-Pey Lin; Yu-Chi Hou; Shang-Yuan Tsai; Meng-Ju Wang; Pei-Dawn Lee Chao
Journal:  Biomedicine (Taipei)       Date:  2014-08-13

7.  Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction.

Authors:  Fenqin Chen; Ning Zhang; Xiaoyu Ma; Ting Huang; Ying Shao; Can Wu; Qiuyue Wang
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

Review 8.  Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

Authors:  Erika Hernández-Aquino; Pablo Muriel
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

9.  Characterization, in Vitro and in Vivo Evaluation of Naringenin-Hydroxypropyl-ß-Cyclodextrin Inclusion for Pulmonary Delivery.

Authors:  Minyi Guan; Rui Shi; Yuying Zheng; Xuan Zeng; Weiyang Fan; Yonggang Wang; Weiwei Su
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

10.  Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of Citrus × aurantium L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Paul Brantom; Andrew Chesson; Johannes Westendorf; Paola Manini; Fabiola Pizzo; Birgit Dusemund
Journal:  EFSA J       Date:  2021-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.